It is also reported that genetic depletion of CCR2+ monocytes (CD11b+Ly6C+) enhances accumulation of adoptively transferred CD8+ T cells in the primary tumor and thereby augments therapeutic effect of the adoptive T-cell therapy on the tumor growth in a melanoma model [49]. This evidence concerns the gene ITGAM and neoplasm.